Treatment retention of dually diagnosed offenders in an institutional therapeutic community

Behavioral Sciences and the Law

Volumn 22, Issue 4, 2004, Pages 585-597

  Van Stelle, Kit R ^a   Blumer, Craig ^b   Moberg, D Paul ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; HYPNOTIC SEDATIVE AGENT; OPIATE; PSYCHEDELIC AGENT;

ADDICTION; ADULT; ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; CRIMINAL JUSTICE; DEMENTIA; DEPRESSION; DRUG ABUSE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIPLE DRUG ABUSE; PERSONALITY DISORDER; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; THERAPEUTIC COMMUNITY; TREATMENT OUTCOME; TREATMENT RETENTION;

ADULT; CRIME; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; INSTITUTIONALIZATION; LENGTH OF STAY; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; RETENTION (PSYCHOLOGY); SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES;

EID: 4043174105     PISSN: 07353936     EISSN: None     Source Type: Journal    
DOI: 10.1002/bsl.602     Document Type: Article

References (56)

1. Aubrey, L. L. (1998). Motivational interviewing with adolescents presenting for outpatient substance abuse treatment. Ph.D. dissertation, University of New Mexico. Dissertation Abstracts International, 59-03B, p. 1,375.
2. Broome, K. M., Flynn, P. M., & Simpson, D. D. (1999). Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research, 34(3), 791-806.
3. Brunette, M. F., Drake, R. E., Woods, M., & Hartnett, T. (2001). A comparison of long-term and short-term residential treatment programs for dual diagnosis patients. Psychiatric Services, 52(4), 526-528.
4. Case, N. (1991). The dual-diagnosis patient in a psychiatric day treatment program: A treatment failure. Journal of Substance Abuse Treatment, 8, 69-73.
5. Cleckly, H. (1976). The mask of insanity (5th ed.). St. Louis, MO: Mosby.
6. Deitch, D. A., Carleton, S., Koutsenok, I. B., & Marsolais, K. (2002). Therapeutic community treatment in prisons. In C. G. Leukefeld, F. Tims, & D. Farabee (Eds.), Treatment of drug offenders: Policies and issues (pp. 127-137). New York: Springer.
7. DeLeon, G., Melnick, G., Kressel, D., & Jainchill, N. (1994). Circumstances, motivation, readiness, and suitability (the CMRS scales): Predicting retention in therapeutic community treatment. American Journal of Drug and Alcohol Abuse, 20(4), 495-515.
8. DeLeon, G., Sacks, S., & Wexler, H. K. (2002). Modified prison therapeutic communities for the dual-and multiple-diagnosed offender. In C. G. Leukefeld, F. Tims, & D. Farabee (Eds.), Treatment of drug offenders: Policies and issues (pp. 138-148). New York: Springer.
9. Ditton, P. M. (1999). Mental health and treatment of inmates and probationers, NCJ 174463. Bureau of Justice Statistics Special Report. Washington, DC: U.S. Department of Justice, Office of Justice Programs. Bureau of Justice Statistics.
10. Drake, R. E., & Mueser, K. T. (1996). Alcohol-use disorder and severe mental illness. Alcohol Health and Research World: Alcoholism and Co-Occurring Disorders, 20(2), 87-93.
11. Drake, R. E., Mueser, K. T., Clark, R. E., & Wallach, M. A. (1996, January). The course, treatment, and outcome of substance disorder in persons with severe mental illness. American Journal of Orthopsychiatry, 66(1), 42-51.
12. Edens, J. F., Peters, R. H., & Hills, H. A. (1997). Treating prison inmates with co-occurring disorders: An integrative review of existing programs. Behavioral Sciences and the Law, 15, 439-457.
13. Evans, K., & Sullivan, J. M. (1990). Dual diagnosis: Counseling the mentally ill substance abuser. New York: Guilford.
14. Field, G. (2002). Historical trends of drug treatment in the criminal justice system. In C. G. Leukefeld, F. Tims, & D. Farabee (Eds.), Treatment of drug offenders: Policies and issues (pp. 9-21). New York: Springer.
15. GAINS. (2002). The prevalence of co-occurring mental illness and substances use disorders in jails. Fact Sheet Series: Delmar, NY. National GAINS Center.
16. Harrison, L. D., & Martin, S. S. (2003). Residential substance abuse treatment for state prisoners: Implementation lessons learned. NIJ Special Report. Washington, DC: National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.
17. Hiller, M. L., Knight, K., Rao, S. R., & Simpson, D. D. (2000). Process assessment of correctional treatment (PACT). NCJ Document No. 184507.
18. Hills, H. (2000). Creating effective treatment programs for persons with co-occurring disorders in the justice system. Delmar, NY: National GAINS Center.
19. Hunt, G. E., Bergen, J., & Bashir, M. (2002). Medication compliance and comorbid substance abuse in schizophrenia: Impact on community survival four years after a relapse. Schizophrenia Research, 54, 253-264.
20. Landry, M. J. (1997). Overview of addiction treatment effectiveness, DHHS Publication No. (SMA) 97-3133. Rockville, MD: National Clearinghouse for Alcohol and Drug Information (NCADI).
21. Lockwood, D., Inciardi, J. A., Butzin, C. A., & Hooper, R. M. (1997). The therapeutic community continuum in corrections. In G. De Leon (Ed.), Community as method: Therapeutic communities for special populations and special settings (pp. 87-96). Westport, CT: Greenwood.
22. Luborsky, L., McLellan, T. A., Woody, G. E., O'Brien, C. P., & Auerbach, A. (1985). Therapist success and its determinants. Archives of General Psychiatry, 42, 602-611.
23. Magura, S., Laudet, A. B., Mahmood, D., Rosenblum, A., & Knight, E. (2002). Adherence to medication regimens and participation in dual-focus self-help groups. Psychiatric Services, 53, 310-316.
24. McCorkel, J. A., Harrison, L. D., & Inciardi, J. A. (1997, August). The construction of treatment among graduates and dropouts in a prison therapeutic community for women. Paper presented at the 92nd Annual Meeting of the American Sociological Association, Toronto.
25. McLellan, A. T. (1983). Predicting response to alcohol and drug abuse treatments: The role of psychiatric severity. Archives of General Psychiatry, 40, 620-625.
26. Messina, N. P., Wish, E. D., & Nemes, S. (1999). Therapeutic community treatment for substance abusers with antisocial personality disorder. Journal of Substance Abuse Treatment, 17(1/2), 121-128.
27. Mierlak, D., Galanter, M., Spivack, N., Dermatis, H., Jurewicz, E., & De Leon, G. (1998). Modified therapeutic community treatment for homeless dually diagnosed men: Who completes treatment? Journal of Substance Abuse Treatment, 15(2), 117-121.
28. Miller, W. R., & Hester, R. K. (1986). The effectiveness of alcoholism treatment: What research reveals. In W. R. Miller, & N. Heather (Eds.), The addictive behaviors: Processes of change (pp. 121-174). New York: Plenum.
29. Minkoff, K. (1989, October). An integrated treatment model for dual diagnosis of psychosis and addiction. Hospital and Community Psychiatry, 40(10), 1031-1036.
30. Minkoff, K. (1991, Summer). New directions for mental health services. Canada: John Wiley & Sons, Ltd.
31. Moggi, F., Crosby Oiumette, P., Finney, J. W., & Moos, R. H. (1999, November). Effectiveness of treatment for substance abuse and dependence for dual diagnosis patients: A model of treatment factors associated with one-year outcomes. Journal of Studies on Alcohol, 60(6), 856.
32. Moos, R. H., Moos, B. S., & Finney, J. W. (2001). Predictors of deterioration among patients with substance-use disorders. Journal of Clinical Psychology, 57(12), 1403-1419.
33. Mueser, K. T., Drake, R. E., & Miles, K. M. (1997). The course and treatment of substance use disorder in persons with severe mental illness. National Institute of Drug Abuse (NIDA) Research Monograph 172: Treatment of Drug Dependent Individuals with Comorbid Mental Disorders. Rockville, MD: U.S. Department of Health and Human Services.
34. Mueser, K. T., Bennett, M., & Kushner, M. G. (1995). Epidemiology of substance use disorders among persons with chronic mental illnesses. In A. F. Lehman, & L. B. Dixon (Eds.), Double jeopardy: Chronic mental illness and substance use disorders (pp. 9-25). Chur, Switzerland: Harwood.
35. National Institute on Drug Abuse. (1999). Principles of drug addiction treatment: A research based guide, NIH Publication No. 99-4180. Washington, DC.
36. O'Keefe, M. L., & Klebe, K. J. (2002). Process evaluation of the Crossroad to Freedom House and Peer I therapeutic communities. NCJ Document No. 192290.
37. Orlinsky, D. E., Grawe, K., & Parks, B. K. (1994). Process and outcome in psychotherapy: Noch ein mal. In A. E. Bergin, & S. L. Garfield (Eds.), Handbook of psychotherapy and behavior change. (4th ed., pp. 270-376). New York: Wiley.
38. Patenaude, A. L., & Laufersweiller-Dwyer, D. L. (2002). Arkansas Comprehensive Substance Abuse Treatment Program: Process evaluation of the modified therapeutic community. NCJ Document No. 191858.
39. Peters, R. H., & Matthews, C. O. (2003). Substance abuse treatment programs in prisons and jails. In T. J. Fagan, & R. K. Ax (Eds.), Correctional mental health handbook. Thousand Oaks, CA: Sage.
40. Prendergast, M., Farabee, D., & Cartier, J. (2001). The impact of in-prison therapeutic community programs on prison management. Journal of Offender Rehabilitation, 32(3), 63-78.
41. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association, 264(19), 2577-2518.
42. Sacks, S., Sacks, J., DeLeon, G., Bernhardt, A., & Staines, G. (1998). Modified therapeutic community for mentally ill chemical abusers: Background; influences; program description; preliminary findings. Substance Use and Misuse, 32(9), 1217-1259.
43. Saunders, B., Wilkinson, E., & Phillips, M. (1995). The impact of a brief motivational intervention with opiate users attending methadone programme. Addictions, 90(3), 415-424.
44. Siegal, H. A., Wang, J., Carlson, R., Russell, G., Falck, S., Rahman, A. M., & Fine, R. L. (1999). Ohio's prison-based therapeutic community treatment program for substance abusers: Preliminary analysis of re-arrest data. Journal of Offender Rehabilitation, 28(3/4), 33-48.
45. Simpson, D. D. (1997, November). Patient engagement and duration of treatment. Paper presented at the National Institutes of Health Consensus Development Conference on Effective Medical Treatment of Heroin Addiction, Bethesda, MD.
46. Simpson, D. D., Joe, G., Broome, K. M., Hiller, M., Knight, K., & Rowan-Szal, G. (1997a). Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 279-293.
47. Simpson, D. D., Joe, G., Rowan-Szal, G., & Greener, J. M. (1997b). Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment, 14(6), 565-572.
48. Stephens, R. S., Roffman, R. A., Cleaveland, B. L., Curtin, L., & Wertz, J. (1994). Extended versus minimal intervention with marijuana dependent adults. Paper presented at the annual meeting of the Association for Advancement of Behavior Therapy, San Diego, CA.
49. U.S. Department of Health and Human Services. (2002, June). The DASIS report: Characteristics of repeat admissions to substance abuse treatment. Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
50. U.S. Department of Justice. (2000, July). Reducing offender drug use through prison-based treatment. National Institute of Justice Journal, 244, 21-23.
51. Van Stelle, K., & Moberg, D. P. (2004). Outcome data for MICA clients after participation in an institutional therapeutic community. Journal of Offender Rehabilitation, 39(1).
52. Walters, G. D. (2003). Predicting criminal justice outcomes with the Psychopathy Checklist and Lifestyle Criminality Screen Form: A meta-analytic comparison. Behavioral Sciences and the Law, 21, 89-102.
53. Welsh, W. N. (2002). Evaluation of prison-based drug treatment in Pennsylvania. A research collaboration between the Pennsylvania Department of Corrections and the Center of Public Policy at Temple University. NCJ Document No. 197058.
54. Westreich, L. M. (1997, April). Treatment for the incarcerated person dually diagnosed with mental illness and addition. Paper presented at the National Corrections Conference on Substance Abuse Testing, Sanctions, and Treatment, New Orleans, LA.
55. Westreich, L., Galanter, M., Lifshutz, H., Metzger, E. J., & Silberstein, C. (1996). A modified therapeutic community for the dually diagnosed: Greenhouse program at Bellevue Hospital. Journal of Substance Abuse Treatment, 13(6), 533-536.
56. Zarkin, G. A., Dunlap, L. J., Bray, J. W., & Wechsberg, W. M. (2002). The effect of treatment completion and length of stay on employment and crime in outpatient drug-free treatment. Journal of Substance Abuse Treatment, 23, 261-271.